Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Validity and reproducibility of a culturally tailored dietary screening tool for hypertension risk in Nigerian healthcare

Nimisoere P. Batubo, Carolyn I. Auma, View ORCID ProfileJ. Bernadette Moore, View ORCID ProfileMichael A. Zulyniak
doi: https://doi.org/10.1101/2024.01.24.24301732
Nimisoere P. Batubo
1Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn I. Auma
1Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Bernadette Moore
1Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Bernadette Moore
Michael A. Zulyniak
1Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, LS2 9JT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael A. Zulyniak
  • For correspondence: m.a.zulyniak{at}leeds.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Food frequency questionnaires (FFQ) are commonly used tools in dietary assessment but require validation. This study aimed to assess the relative validity and reproducibility of a culturally tailored FFQ for estimating food intake among Nigerian adults in clinical settings. The FFQ was administered to 58 patients at the Rivers State University Teaching Hospital, Nigeria, on two occasions, two weeks apart. Three repeat non-consecutive 24-hour dietary recalls (24DR) were also conducted as a reference method to evaluate the validity of the FFQ. Spearman’s rank correlations, Wilcoxon signed-rank tests, cross-classification agreement, intraclass correlation coefficients (ICC), and Bland-Altman analysis were performed in R to evaluate the relative validity and reproducibility. The trial was registered with ClinicalTrials.gov: NCT05973760. The correlation coefficient (rs) between the FFQ and 24DR ranged from 0.20 for ‘fats and oils’ to 0.78 for vegetables, with an average rs of 0.60 (p<0.05). The Wilcoxon signed-rank tests indicated no significant differences in the 19 food groups queried (p>0.05), except for fats and oils (p<0.05). The exact agreement between FFQ and 24DR for classifying individuals into quartiles ranged from 17% for salt to 88% for processed meats and alcoholic drinks, with 90% of individuals classified into the same or neighbouring quartile. Additionally, the Bland-Altman analysis demonstrated acceptable agreement, with > 96% of observations within the acceptable limits of agreement for all food groups. For reproducibility, the ICC ranged from 0.31 for stew to 0.98 for fruit, with an average ICC of 0.77 between the FFQs delivered two weeks apart. These data demonstrate good agreement between our culturally tailored FFQ and 24DR, and moreover, robust reproducibility for quantifying intakes of food groups associated with hypertension in Nigeria. This confirms that this novel FFQ is a valid and reliable tool for assessing the intake of key food groups among Nigerian adults.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT05973760

Clinical Protocols

https://www.medrxiv.org/content/10.1101/2023.09.25.23296109v1

Funding Statement

This study was funded by the Tertiary Education Trust Fund (TETFund) of Nigeria. MAZ is currently funded by Wellcome Trust (217446/Z/19/Z). The funders do not have any role in any aspect of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol underwent review by two ethics boards. Firstly, it was submitted to the Business, Earth & Environment, Social Sciences (AREA FREC) Committee at the University of Leeds, Leeds, United Kingdom, and was granted ethical approval (0484) on 28/04/2023. Secondly, it was presented to the Rivers State University Teaching Hospital Research Ethics Committee in Port Harcourt, Nigeria, and received ethical approval (RSUTH/REC/2023316) on 30/03/2023.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The values behind the means, standard deviations and other measures are reported and the data has been made privately available for reviewers at: https://data.4tu.nl/private_datasets/LG8jdbsGJQz5hA6vL1ik_-5OvufCdpcAeHnIdtbP-n8. We have embargoed the data for release until publication of the manuscript or the lead author (PhD student) has completed their PhD (August 2024), whoever happens first.

https://data.4tu.nl/private_datasets/LG8jdbsGJQz5hA6vL1ik_-5OvufCdpcAeHnIdtbP-n8

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 24, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Validity and reproducibility of a culturally tailored dietary screening tool for hypertension risk in Nigerian healthcare
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Validity and reproducibility of a culturally tailored dietary screening tool for hypertension risk in Nigerian healthcare
Nimisoere P. Batubo, Carolyn I. Auma, J. Bernadette Moore, Michael A. Zulyniak
medRxiv 2024.01.24.24301732; doi: https://doi.org/10.1101/2024.01.24.24301732
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Validity and reproducibility of a culturally tailored dietary screening tool for hypertension risk in Nigerian healthcare
Nimisoere P. Batubo, Carolyn I. Auma, J. Bernadette Moore, Michael A. Zulyniak
medRxiv 2024.01.24.24301732; doi: https://doi.org/10.1101/2024.01.24.24301732

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)